Učitavanje...
Anti PD-1 and Anti PD-L1 Monoclonal Antibodies in People Living with HIV and Cancer
PURPOSE OF REVIEW: Immune checkpoint inhibitors targeting the programmed cell death-1 (PD-1) pathway are a class of anti-cancer immunotherapy agents changing treatment paradigms of many cancers that occur at higher rates in people living with HIV (PLWH) than in the general population. However, PLWH...
Spremljeno u:
| Izdano u: | Curr HIV/AIDS Rep |
|---|---|
| Glavni autori: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2020
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7799392/ https://ncbi.nlm.nih.gov/pubmed/32827111 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11904-020-00525-y |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|